① At the collective bidding stage this morning, the easy transaction of 54,000 yuan hit a “20cm” drop. Since then, the stock price has quickly risen above 37 yuan. ② Net profit attributable to shareholders of listed companies was 9.015 million, and losses for 6 consecutive quarters easily turned a loss into a profit. However, the net profit loss attributable to shareholders of listed companies in the first three quarters was about 16.33 million yuan.
“Science and Technology Innovation Board Daily”, December 1 (Reporter Xu Cihao) “It's not easy.” Today's stock prices are “not easy.”
At the collective bidding stage this morning, the stock traded at 54,000 yuan and hit a “20cm” drop. Since then, the stock price has quickly risen above 37 yuan. At the close, down 2.02%, it closed at 3738 yuan, with a full day turnover of 33.58 million yuan.
In response to the trend of collective bidding this morning, the “Science and Technology Innovation Board Daily” reporter called Bijianping as an investor. The operator said that there were no problems at the company's management level. After understanding, the most common reason was due to investors placing wrong orders.
On October 30, Pixuan released a financial report showing that the company's third-quarter revenue was 342 million yuan, up 79.81% year on year; in the first three quarters, the company achieved revenue of 942 million yuan, up 45.10% year on year. Total revenue for the first three quarters had already surpassed last year's overall revenue, setting the best revenue data for the same period in the past four years.
In terms of profit, net profit attributable to shareholders of listed companies was 9.015 million, and losses for six consecutive quarters easily turned losses into profits. However, the net profit loss attributable to shareholders of listed companies in the first three quarters was about 16.33 million yuan.
Beiliang was founded in July 2000, launched its first eye massager product in 2001, and officially entered the massager industry. In July 2021, Bieasy entered the Science and Technology Innovation Board as the “first stock of smart massage equipment”. At the opening of the market, it once rose to a historically high price of 131.78 yuan/share, a sharp increase of 380.94% from the issue price of 27.4 yuan/share. Since then, the stock price has declined all the way down.
As a science and technology innovation board company, Beilian positions itself as “a high-tech enterprise focusing on innovative research and development of health products.”
However, the “technological content” of easy times has been criticized for a long time.
According to the data, from 2018 to 2022, Bieasy's R&D expenses were 255.78 million yuan, 406567 million yuan, 368.912 million yuan, 47.205 million yuan, and 57.3282 million yuan respectively, accounting for 6%, 4.4%, 4%, and 6.4% of total revenue, respectively.
In the first half of this year, Bieasy's R&D investment accounted for 4.42% of revenue, a decrease of 2.19 percentage points over the previous year.